TEE as a Guide for Fluid Optimization in Major Abdominal Oncosurgery
VTI SVV
Transesophageal Echocardiography as a Guide for Fluid Optimization in Major Abdominal Oncosurgery
1 other identifier
interventional
60
1 country
1
Brief Summary
Transesophageal echocardiography (TEE) as guide for tailoring perioperative fluid therapy to achieve individualized hemodynamic endpoint, target hemodynamic goals of stroke volume index (SVI) greater than 35 mL/m2 and cardiac index greater than 2.5 L/min/m2 and tissue oxygen delivery. Lactate levels as a surrogate indicator of organ perfusion as measured by arterial blood gas analysis intraoperatively, after 12 hours and 48 hrs postoperatively
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2017
CompletedFirst Posted
Study publicly available on registry
May 4, 2017
CompletedStudy Start
First participant enrolled
February 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 27, 2020
CompletedOctober 26, 2020
October 1, 2020
1 year
April 15, 2017
October 22, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative complications
The incidence of postoperative complications in percentage
48 hours
Secondary Outcomes (2)
intraoperative fluid
intraoperative period (hours)
median icu stay
1 week
Study Arms (2)
Group A (stroke volume variation) guided fluid
ACTIVE COMPARATORStroke volume variation guided intraoperative intravenous fluid will be administered.
Group B(Study group) TEE guided fluid
ACTIVE COMPARATORTransesophageal echocardiography will be used to guide the fluid therapy.
Interventions
Transesophageal echocardiography will be used to guide the fluid therapy. Velocity time integral of aorta \<20 ,200ml colloid bolus to be administered.
Active Comparator: Group A control group (SVV guided fluid ) Stroke volume variation guided intraoperative intravenous fluid will be administered. SVV \>10, 200 ml of colloid bolus to be given
Eligibility Criteria
You may qualify if:
- ASA 1, 2 and 3
- Undergoing major abdominal oncosurgery
You may not qualify if:
- Any contraindication for TEE probe insertion as oesophageal varices , oesophageal and gastric carcinoma , severe left ventricular hypertrophy , coagulopathy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rajiv Gandhi Cancer Institute
Delhi, 110085, India
Related Publications (2)
Guarracino F. [The role of transesophageal echocardiography in intraoperative hemodynamic monitoring]. Minerva Anestesiol. 2001 Apr;67(4):320-4. Italian.
PMID: 11376533RESULTTrinooson CD, Gold ME. Impact of goal-directed perioperative fluid management in high-risk surgical procedures: a literature review. AANA J. 2013 Oct;81(5):357-68.
PMID: 24354071RESULT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Masking Details
- The intensivist taking care of the patient postoperatively not aware of the intervention
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 15, 2017
First Posted
May 4, 2017
Study Start
February 16, 2019
Primary Completion
February 27, 2020
Study Completion
February 27, 2020
Last Updated
October 26, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share